Other Events


Optimising Prostate Cancer Diagnostics

 Date: Thursday 9 to Friday 10October 2014

Location: Guy's Hospital, London, UK

Registration:  Secure your place here

Website: www.guysandstthomasevents.co.uk

This highly practical two day course provides an update on the use of mp MRI transperineal and transrectal biopsies in prostate diagnostics.

At Guy's Hospital, we’re proud to have developed a practical, pathologically-friendly Transperineal Sector Biopsy (TPSB) protocol which preferentially targets the peripheral zone by sectors and requires 24 - 32 cores only. This course will provide practical instruction of the TP sector biopsy protocol with US stations and the use of biopsy phantoms

Join us for on Thursday 9 to Friday 10 October to discover more - particularly if you’re considering starting TP biopsies or if you’re currently involved in carrying-out TP biopsies (i.e. nurse practitioners, theatre nurses, consultants, registrars, pathologists and radiologists). 

Course highlights:

  • Live cases of transperineal sector biopsy with expert commentary and guidance
  • Pathological processing and reporting
  • TPSB in clinical practice
  • The Guy’s Experience of MRI-US Fusion Targeted Biopsies
  • Faculty of experts led by Consultant Urologist Mr Rick Popert and Netty Kinsella, Advanced Nurse Practitioner
  • CPD points awarded

For further information and to register your place online, please visit the Optimising Prostate Cancer Diagnostics page on our website.



The Royal Marsden Bladder and Testicular Cancer Conference

Treatment dilemmas and the pivotal points in their immediate and long term care

Friday 10 October 2014

The Royal Marsden Conference Centre, Stewart’s Grove, London, SW3 6JJ
Email Address: conferenceteam@rmh.nhs.uk
Phone Number: +44 (0)207 808 2921

Website: www.royalmarsden.nhs.uk/bladdertesticular

It is with pleasure that we invite you to participate in this exciting conference on testicular and bladder cancer. The former is a disease largely restricted to young adult men whereas the latter affects both sexes at a later stage in life. Despite these differences, they are both characterised by successful outcomes associated with multidisciplinary care which combines surgery, chemotherapy and radiotherapy for locally advanced and metastatic disease, as well as rigorous surveillance strategies for low stage tumours.
In both, treatments can be associated with consequences that impact on quality of life and body image issues which influence treatment decisions. Consequently, management is underpinned by a multidisciplinary approach dealing with both effective treatment of the cancer, as well as the resulting side effects. Balancing these conflicting issues is one of the major challenges in caring for such patients.
A specific challenge for clinicians is to ensure that radical therapies, usually requiring a combination of modalities, is appropriately provided to optimise outcome, balanced by the need to avoid over-treatment in selected patients who will experience unnecessary treatment-related morbidity. Care is thus underpinned by management to ensure the best outcome for individual patients.
Through interactive case discussions, we will highlight the treatment dilemmas confronting patients with both these diseases and the pivotal points to be considered in their immediate and long-term care.

Professor David Nicol

Consultant Urological Surgeon/Chief of Surgery

Mr. Pardeep Kumar

Consultant Urological Surgeon